Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
2016 · New England Journal of Medicine · 1,764 citations
https://doi.org/10.1056/nejmoa1602773
S
Scott D. Lee
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
211
Papers
5.6K
Citations
32
h-index
60
i10-index
Scott D. Lee is an academic researcher from University of Washington. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 32, co-authored 180 publications.
ORCID: 0000-0001-8936-8052Papers by this author
worksPhase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study
2017 · Gut · 107 citations
https://doi.org/10.1136/gutjnl-2016-313457
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
2018 · Digestive Diseases and Sciences · 72 citations
https://doi.org/10.1007/s10620-018-4971-1
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
2024 · Inflammatory Bowel Diseases · 46 citations
https://doi.org/10.1093/ibd/izae024
Differentiation of brain and retinal organoids from confluent cultures of pluripotent stem cells connected by nerve-like axonal projections of optic origin
2022 · Stem Cell Reports · 45 citations
https://doi.org/10.1016/j.stemcr.2022.04.003
Somatic and Stem Cell Bank to study the contribution of African ancestry to dementia: African iPSC Initiative
2025 · Alzheimer s & Dementia · 1 citations
https://doi.org/10.1002/alz.70145
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat